Global Vasomotor Symptoms of Menopause Treatment Market 2018 - Research Report, Demand, Price, By Application, Region and Forecast to 2023

 Published Date : Apr-2018   |    Format :PDF |    Number of Pages : 122   |    Publisher : e-Market Research

Summary

This report studies the Vasomotor Symptoms of Menopause Treatment market status and outlook of global and United States, from angles of players, regions, product types and end industries; this report analyzes the top players in global and United States market, and splits the Vasomotor Symptoms of Menopause Treatment market by product type and application/end industries.

The global Vasomotor Symptoms of Menopause Treatment market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially the United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Vasomotor Symptoms of Menopause Treatment.

United States plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of XX.

Geographically, this report is segmented into several key regions, with sales, revenue, market share (%) and growth Rate (%) of Vasomotor Symptoms of Menopause Treatment in these regions, from 2013 to 2025 (forecast), covering
    United States
    North America
    Europe
    Asia-Pacific
    South America
    Middle East and Africa

The major players in global and United States market, including
    Amgen Inc.
    EndoCeutics, Inc.
    Euroscreen S.A.
    MenoGeniX, Inc.
    Mithra Pharmaceuticals S.A.
    Pherin Pharmaceuticals, Inc.
    Pivot Pharmaceuticals Inc
    Radius Health, Inc.
    TherapeuticsMD, Inc.
On the basis of product, the market is primarily split into
    Estetrol
    Fezolinetant
    FP-101
    HBN-2
    Others
On the basis on the end users/application, this report covers
    Hospital
    Homecare
    Clinic

2018-2025 Vasomotor Symptoms of Menopause Treatment Report on Global and United States Market, Status and Forecast, by Players, Types and Applications
1 Methodology and Data Source
    1.1 Methodology/Research Approach
        1.1.1 Research Programs/Design
        1.1.2 Market Size Estimation
        1.1.3 Market Breakdown and Data Triangulation
    1.2 Data Source
        1.2.1 Secondary Sources
        1.2.2 Primary Sources
    1.3 Disclaimer

2 Vasomotor Symptoms of Menopause Treatment Market Overview
    2.1 Vasomotor Symptoms of Menopause Treatment Product Overview
    2.2 Vasomotor Symptoms of Menopause Treatment Market Segment by Type
        2.2.1 Estetrol
        2.2.2 Fezolinetant
        2.2.3 FP-101
        2.2.4 HBN-2
        2.2.5 Others
    2.3 Global Vasomotor Symptoms of Menopause Treatment Product Segment by Type
        2.3.1 Global Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Growth (%) by Type (2013, 2017 and 2025)
        2.3.2 Global Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Market Share (%) by Type (2013-2018)
        2.3.3 Global Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Market Share (%) by Type (2013-2018)
        2.3.4 Global Vasomotor Symptoms of Menopause Treatment Price (USD/Pcs) by Type (2013-2018)
    2.4 United States Vasomotor Symptoms of Menopause Treatment Product Segment by Type
        2.4.1 United States Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Growth by Type (2013, 2017 and 2025)
        2.4.2 United States Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Market Share by Type (2013-2018)
        2.4.3 United States Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Market Share by Type (2013-2018)
        2.4.4 United States Vasomotor Symptoms of Menopause Treatment Price (USD/Pcs) by Type (2013-2018)

3 Vasomotor Symptoms of Menopause Treatment Application/End Users
    3.1 Vasomotor Symptoms of Menopause Treatment Segment by Application/End Users
        3.1.1 Hospital
        3.1.2 Homecare
        3.1.3 Clinic
    3.2 Global Vasomotor Symptoms of Menopause Treatment Product Segment by Application
        3.2.1 Global Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and CGAR (%) by Application (2013, 2017 and 2025)
        3.2.2 Global Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Market Share (%) by Application (2013-2018)
    3.3 United States Vasomotor Symptoms of Menopause Treatment Product Segment by Application
        3.3.1 United States Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and CGAR (%) by Application (2013, 2017 and 2025)
        3.3.2 United States Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Market Share (%) by Application (2013-2018)

4 Vasomotor Symptoms of Menopause Treatment Market Status and Outlook by Regions
    4.1 Global Market Status and Outlook by Regions
        4.1.1 Global Vasomotor Symptoms of Menopause Treatment Market Size and CAGR by Regions (2013, 2017 and 2025)
        4.1.2 North America
        4.1.3 Asia-Pacific
        4.1.4 Europe
        4.1.5 South America
        4.1.6 Middle East and Africa
        4.1.7 United States
    4.2 Global Vasomotor Symptoms of Menopause Treatment Sales and Revenue by Regions
        4.2.1 Global Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Market Share (%) by Regions (2013-2018)
        4.2.2 Global Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Market Share (%) by Regions (2013-2018)
        4.2.3 Global Vasomotor Symptoms of Menopause Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
        4.2.4 North America Vasomotor Symptoms of Menopause Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
        4.2.5 Europe Vasomotor Symptoms of Menopause Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
        4.2.6 Asia-Pacific Vasomotor Symptoms of Menopause Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
        4.2.7 South America Vasomotor Symptoms of Menopause Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
        4.2.8 Middle East and Africa Vasomotor Symptoms of Menopause Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
        4.2.9 United States Vasomotor Symptoms of Menopause Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

5 Global Vasomotor Symptoms of Menopause Treatment Market Competition by Players/Manufacturers
    5.1 Global Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Market Share by Players (2013-2018)
    5.2 Global Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Share by Players (2013-2018)
    5.3 Global Vasomotor Symptoms of Menopause Treatment Average Price (USD/Pcs) by Players (2013-2018)
    5.4 Global Top Players Vasomotor Symptoms of Menopause Treatment Manufacturing Base Distribution, Sales Area, Product Types
    5.5 Vasomotor Symptoms of Menopause Treatment Market Competitive Situation and Trends
        5.5.1 Vasomotor Symptoms of Menopause Treatment Market Concentration Rate
        5.5.2 Global Vasomotor Symptoms of Menopause Treatment Market Share (%) of Top 3 and Top 5 Players
        5.5.3 Mergers & Acquisitions, Expansion

6 United States Vasomotor Symptoms of Menopause Treatment Market Competition by Players/Manufacturers
    6.1 United States Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Market Share by Players (2013-2018)
    6.2 United States Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Share by Players (2013-2018)
    6.3 United States Vasomotor Symptoms of Menopause Treatment Average Price (USD/Pcs) by Players (2013-2018)
    6.4 United States Vasomotor Symptoms of Menopause Treatment Market Share (%) of Top 3 and Top 5 Players


7 Vasomotor Symptoms of Menopause Treatment Players/Manufacturers Profiles and Sales Data
    7.1 Amgen Inc.
        7.1.1 Company Basic Information, Manufacturing Base and Competitors
        7.1.2 Vasomotor Symptoms of Menopause Treatment Product Category, Application and Specification
            7.1.2.1 Product A
            7.1.2.2 Product B
        7.1.3 Amgen Inc. Vasomotor Symptoms of Menopause Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
        7.1.4 Main Business/Business Overview
    7.2 EndoCeutics, Inc.
        7.2.1 Company Basic Information, Manufacturing Base and Competitors
        7.2.2 Vasomotor Symptoms of Menopause Treatment Product Category, Application and Specification
            7.2.2.1 Product A
            7.2.2.2 Product B
        7.2.3 EndoCeutics, Inc. Vasomotor Symptoms of Menopause Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
        7.2.4 Main Business/Business Overview
    7.3 Euroscreen S.A.
        7.3.1 Company Basic Information, Manufacturing Base and Competitors
        7.3.2 Vasomotor Symptoms of Menopause Treatment Product Category, Application and Specification
            7.3.2.1 Product A
            7.3.2.2 Product B
        7.3.3 Euroscreen S.A. Vasomotor Symptoms of Menopause Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
        7.3.4 Main Business/Business Overview
    7.4 MenoGeniX, Inc.
        7.4.1 Company Basic Information, Manufacturing Base and Competitors
        7.4.2 Vasomotor Symptoms of Menopause Treatment Product Category, Application and Specification
            7.4.2.1 Product A
            7.4.2.2 Product B
        7.4.3 MenoGeniX, Inc. Vasomotor Symptoms of Menopause Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
        7.4.4 Main Business/Business Overview
    7.5 Mithra Pharmaceuticals S.A.
        7.5.1 Company Basic Information, Manufacturing Base and Competitors
        7.5.2 Vasomotor Symptoms of Menopause Treatment Product Category, Application and Specification
            7.5.2.1 Product A
            7.5.2.2 Product B
        7.5.3 Mithra Pharmaceuticals S.A. Vasomotor Symptoms of Menopause Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
        7.5.4 Main Business/Business Overview
    7.6 Pherin Pharmaceuticals, Inc.
        7.6.1 Company Basic Information, Manufacturing Base and Competitors
        7.6.2 Vasomotor Symptoms of Menopause Treatment Product Category, Application and Specification
            7.6.2.1 Product A
            7.6.2.2 Product B
        7.6.3 Pherin Pharmaceuticals, Inc. Vasomotor Symptoms of Menopause Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
        7.6.4 Main Business/Business Overview
    7.7 Pivot Pharmaceuticals Inc
        7.7.1 Company Basic Information, Manufacturing Base and Competitors
        7.7.2 Vasomotor Symptoms of Menopause Treatment Product Category, Application and Specification
            7.7.2.1 Product A
            7.7.2.2 Product B
        7.7.3 Pivot Pharmaceuticals Inc Vasomotor Symptoms of Menopause Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
        7.7.4 Main Business/Business Overview
    7.8 Radius Health, Inc.
        7.8.1 Company Basic Information, Manufacturing Base and Competitors
        7.8.2 Vasomotor Symptoms of Menopause Treatment Product Category, Application and Specification
            7.8.2.1 Product A
            7.8.2.2 Product B
        7.8.3 Radius Health, Inc. Vasomotor Symptoms of Menopause Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
        7.8.4 Main Business/Business Overview
    7.9 TherapeuticsMD, Inc.
        7.9.1 Company Basic Information, Manufacturing Base and Competitors
        7.9.2 Vasomotor Symptoms of Menopause Treatment Product Category, Application and Specification
            7.9.2.1 Product A
            7.9.2.2 Product B
        7.9.3 TherapeuticsMD, Inc. Vasomotor Symptoms of Menopause Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
        7.9.4 Main Business/Business Overview

8 Vasomotor Symptoms of Menopause Treatment Manufacturing Cost, Industrial Chain and Downstream Buyers
    8.1 Vasomotor Symptoms of Menopause Treatment Key Raw Materials Analysis
        8.1.1 Key Raw Materials
        8.1.2 Price Trend of Key Raw Materials
        8.1.3 Key Suppliers of Raw Materials
        8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
        8.2.1 Raw Materials
        8.2.2 Labor Cost
        8.2.3 Manufacturing Expenses
    8.3 Vasomotor Symptoms of Menopause Treatment Industrial Chain Analysis
    8.4 Downstream Buyers in United States

9 Marketing Strategy Analysis, Distributors and Market Effect Factors
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Distributors in Untied States
    9.3 Market Effect Factors Analysis
        9.3.1 Economic/Political Environmental Change
        9.3.2 Downstream Demand Change
        9.3.3 Technology Progress in Related Industry
        9.3.4 Substitutes Threat

10 Global Vasomotor Symptoms of Menopause Treatment Market Forecast
    10.1 Global Vasomotor Symptoms of Menopause Treatment Sales, Revenue Forecast (2018-2025)
        10.1.1 Global Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
        10.1.2 Global Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
    10.2 United States Vasomotor Symptoms of Menopause Treatment Market Forecast
        10.2.1 United States Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
        10.2.2 United States Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
    10.3 Global Vasomotor Symptoms of Menopause Treatment Forecast by Regions
        10.3.1 North America Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
        10.3.2 Europe Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
        10.3.3 Asia-Pacific Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
        10.3.4 South America Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
        10.3.5 Middle East and Africa Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
    10.4 Vasomotor Symptoms of Menopause Treatment Forecast by Type
        10.4.1 Global Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Revenue (Million USD) Forecast by Type (2018-2025)
        10.4.2 United States Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Revenue (Million USD) Forecast by Type (2018-2025)
    10.5 Vasomotor Symptoms of Menopause Treatment Forecast by Application
        10.5.1 Global Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) Forecast by Application (2018-2025)
        10.5.2 United States Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) Forecast by Application (2018-2025)

11 Research Findings and Conclusion
List of Tables and Figures

    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources
    Figure Vasomotor Symptoms of Menopause Treatment Product Picture
    Figure Global Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) Status and Outlook (2013-2025)
    Figure United States Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) Status and Outlook (2013-2025)
    Figure Product Picture of Estetrol
    Table Major Players of Estetrol
    Figure Global Estetrol Sales (K Pcs) and Growth Rate (%)(2013-2018)
    Figure Product Picture of Fezolinetant
    Table Major Players of Fezolinetant
    Figure Global Fezolinetant Sales (K Pcs) and Growth Rate (%)(2013-2018)
    Figure Product Picture of FP-101
    Table Major Players of FP-101
    Figure Global FP-101 Sales (K Pcs) and Growth Rate (%)(2013-2018)
    Figure Product Picture of HBN-2
    Table Major Players of HBN-2
    Figure Global HBN-2 Sales (K Pcs) and Growth Rate (%)(2013-2018)
    Figure Product Picture of Others
    Table Major Players of Others
    Figure Global Others Sales (K Pcs) and Growth Rate (%)(2013-2018)
    Table Global Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Growth Rate (%) Comparison by Type (2013, 2017 and 2025)
    Table Global Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) by Type (2013-2018)
    Table Global Vasomotor Symptoms of Menopause Treatment Sales Share (%) by Type (2013-2018)
    Figure Global Vasomotor Symptoms of Menopause Treatment Sales Market Share (%) by Type (2013-2018)
    Figure Global Vasomotor Symptoms of Menopause Treatment Sales Market Share (%) by Type in 2017
    Table Global Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) by Type (2013-2018)
    Table Global Vasomotor Symptoms of Menopause Treatment Revenue Share (%) by Type (2013-2018)
    Figure Global Vasomotor Symptoms of Menopause Treatment Revenue Share (%) by Type (2013-2018)
    Figure 2017 Global Vasomotor Symptoms of Menopause Treatment Revenue Market Share (%) by Type
    Table Global Vasomotor Symptoms of Menopause Treatment Price (USD/Pcs) by Type (2013-2018)
    Table United States Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Growth Rate (%) Comparison by Type (2013, 2017 and 2025)
    Table United States Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) by Type (2013-2018)
    Table United States Vasomotor Symptoms of Menopause Treatment Sales Share (%) by Type (2013-2018)
    Figure United States Vasomotor Symptoms of Menopause Treatment Sales Market Share (%) by Type (2013-2018)
    Figure United States Vasomotor Symptoms of Menopause Treatment Sales Market Share (%) by Type in 2017
    Table United States Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) by Type (2013-2018)
    Table United States Vasomotor Symptoms of Menopause Treatment Revenue Share (%) by Type (2013-2018)
    Figure United States Vasomotor Symptoms of Menopause Treatment Revenue Share (%)by Type (2013-2018)
    Figure 2017 United States Vasomotor Symptoms of Menopause Treatment Revenue Market Share (%) by Type
    Table United States Vasomotor Symptoms of Menopause Treatment Price (USD/Pcs) by Type (2013-2018)
    Figure Hospital Examples
    Figure Homecare Examples
    Figure Clinic Examples
    Table Global Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) Comparison by Application (2013-2025)
    Table Global Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) by Application (2013-2018)
    Table Global Vasomotor Symptoms of Menopause Treatment Sales Share (%) by Application (2013-2018)
    Figure Global Vasomotor Symptoms of Menopause Treatment Sales Market Share (%) by Application (2013-2018)
    Figure Global Vasomotor Symptoms of Menopause Treatment Sales Market Share (%) by Application in 2017
    Table United States Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) Comparison by Application (2013-2025)
    Table United States Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) by Application (2013-2018)
    Table United States Vasomotor Symptoms of Menopause Treatment Sales Share (%) by Application (2013-2018)
    Figure United States Vasomotor Symptoms of Menopause Treatment Sales Market Share (%) by Application (2013-2018)
    Figure United States Vasomotor Symptoms of Menopause Treatment Sales Market Share (%) by Application in 2017
    Table Global Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and CAGR Comparison by Regions (2013-2025)
    Figure North America Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate (%)(2013-2025)
    Figure Asia-Pacific Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate (%)(2013-2025)
    Figure Europe Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate (%)(2013-2025)
    Figure South America Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate (%)(2013-2025)
    Figure Middle East and Africa Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate (%)(2013-2025)
    Figure United States Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate (%)(2013-2025)
    Table Global Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) by Regions (2013-2018)
    Table Global Vasomotor Symptoms of Menopause Treatment Sales Market Share (%) by Regions (2013-2018)
    Figure Global Vasomotor Symptoms of Menopause Treatment Sales Market Share (%) by Regions (2013-2018)
    Figure 2017 Global Vasomotor Symptoms of Menopause Treatment Sales Market Share (%) by Regions
    Figure 2017 United States Vasomotor Symptoms of Menopause Treatment Sales Market Share (%) in Global Market
    Table Global Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) by Regions (2013-2018)
    Table Global Vasomotor Symptoms of Menopause Treatment Revenue Market Share (%) by Regions (2013-2018)
    Figure Global Vasomotor Symptoms of Menopause Treatment Revenue Market Share (%) by Regions (2013-2018)
    Figure 2017 Global Vasomotor Symptoms of Menopause Treatment Revenue Market Share (%) by Regions
    Figure 2017 United States Vasomotor Symptoms of Menopause Treatment Revenue Market Share (%) in Global Market
    Table Global Vasomotor Symptoms of Menopause Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
    Table North America Vasomotor Symptoms of Menopause Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
    Table Europe Vasomotor Symptoms of Menopause Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
    Table Asia-Pacific Vasomotor Symptoms of Menopause Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
    Table South America Vasomotor Symptoms of Menopause Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
    Table Middle East and Africa Vasomotor Symptoms of Menopause Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
    Table United States Vasomotor Symptoms of Menopause Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
    Table Global Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) of Key Players (2013-2018)
    Table Global Vasomotor Symptoms of Menopause Treatment Sales Share (%) by Players (2013-2018)
    Figure 2017 Global Vasomotor Symptoms of Menopause Treatment Sales Share (%) by Players
    Figure 2018 Global Vasomotor Symptoms of Menopause Treatment Sales Share (%) by Players
    Table Global Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) by Players (2013-2018)
    Table Global Vasomotor Symptoms of Menopause Treatment Revenue Share (%) by Players (2013-2018)
    Table 2017 Global Vasomotor Symptoms of Menopause Treatment Revenue Share (%) by Players
    Table 2018 Global Vasomotor Symptoms of Menopause Treatment Revenue Share (%) by Players
    Table Global Market Vasomotor Symptoms of Menopause Treatment Average Price (USD/Pcs) by Players (2013-2018)
    Table Global Vasomotor Symptoms of Menopause Treatment Top Players Manufacturing Base Distribution and Sales Area
    Table Global Vasomotor Symptoms of Menopause Treatment Top Players Product Category
    Figure Global Vasomotor Symptoms of Menopause Treatment Market Share (%) of Top 3 Players
    Figure Global Vasomotor Symptoms of Menopause Treatment Market Share (%) of Top 5 Players
    Table United States Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) by Players (2013-2018)
    Table United States Vasomotor Symptoms of Menopause Treatment Sales Market Share (%) by Players (2013-2018)
    Figure 2017 United States Vasomotor Symptoms of Menopause Treatment Sales Share (%) by Players
    Figure 2018 United States Vasomotor Symptoms of Menopause Treatment Sales Share (%) by Players
    Table United States Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) by Players (2013-2018)
    Table United States Vasomotor Symptoms of Menopause Treatment Revenue Market Share (%) by Players (2013-2018)
    Table 2017 United States Vasomotor Symptoms of Menopause Treatment Revenue Share (%) by Players
    Table 2018 United States Vasomotor Symptoms of Menopause Treatment Revenue Share (%) by Players
    Table United States Market Vasomotor Symptoms of Menopause Treatment Average Price (USD/Pcs) by Players (2013-2018)
    Figure United States Vasomotor Symptoms of Menopause Treatment Market Share (%) of Top 3 Players
    Figure United States Vasomotor Symptoms of Menopause Treatment Market Share (%) of Top 5 Players
    Table Amgen Inc. Basic Information List
    Table Amgen Inc. Vasomotor Symptoms of Menopause Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
    Figure Amgen Inc. Vasomotor Symptoms of Menopause Treatment Sales Growth Rate (2013-2018)
    Figure Amgen Inc. Vasomotor Symptoms of Menopause Treatment Sales Global Market Share (%)(2013-2018)
    Figure Amgen Inc. Vasomotor Symptoms of Menopause Treatment Revenue Global Market Share (%)(2013-2018)
    Table EndoCeutics, Inc. Basic Information List
    Table EndoCeutics, Inc. Vasomotor Symptoms of Menopause Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
    Figure EndoCeutics, Inc. Vasomotor Symptoms of Menopause Treatment Sales Growth Rate (2013-2018)
    Figure EndoCeutics, Inc. Vasomotor Symptoms of Menopause Treatment Sales Global Market Share (%)(2013-2018)
    Figure EndoCeutics, Inc. Vasomotor Symptoms of Menopause Treatment Revenue Global Market Share (%)(2013-2018)
    Table Euroscreen S.A. Basic Information List
    Table Euroscreen S.A. Vasomotor Symptoms of Menopause Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
    Figure Euroscreen S.A. Vasomotor Symptoms of Menopause Treatment Sales Growth Rate (2013-2018)
    Figure Euroscreen S.A. Vasomotor Symptoms of Menopause Treatment Sales Global Market Share (%)(2013-2018)
    Figure Euroscreen S.A. Vasomotor Symptoms of Menopause Treatment Revenue Global Market Share (%)(2013-2018)
    Table MenoGeniX, Inc. Basic Information List
    Table MenoGeniX, Inc. Vasomotor Symptoms of Menopause Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
    Figure MenoGeniX, Inc. Vasomotor Symptoms of Menopause Treatment Sales Growth Rate (2013-2018)
    Figure MenoGeniX, Inc. Vasomotor Symptoms of Menopause Treatment Sales Global Market Share (%)(2013-2018)
    Figure MenoGeniX, Inc. Vasomotor Symptoms of Menopause Treatment Revenue Global Market Share (%)(2013-2018)
    Table Mithra Pharmaceuticals S.A. Basic Information List
    Table Mithra Pharmaceuticals S.A. Vasomotor Symptoms of Menopause Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
    Figure Mithra Pharmaceuticals S.A. Vasomotor Symptoms of Menopause Treatment Sales Growth Rate (2013-2018)
    Figure Mithra Pharmaceuticals S.A. Vasomotor Symptoms of Menopause Treatment Sales Global Market Share (%)(2013-2018)
    Figure Mithra Pharmaceuticals S.A. Vasomotor Symptoms of Menopause Treatment Revenue Global Market Share (%)(2013-2018)
    Table Pherin Pharmaceuticals, Inc. Basic Information List
    Table Pherin Pharmaceuticals, Inc. Vasomotor Symptoms of Menopause Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
    Figure Pherin Pharmaceuticals, Inc. Vasomotor Symptoms of Menopause Treatment Sales Growth Rate (2013-2018)
    Figure Pherin Pharmaceuticals, Inc. Vasomotor Symptoms of Menopause Treatment Sales Global Market Share (%)(2013-2018)
    Figure Pherin Pharmaceuticals, Inc. Vasomotor Symptoms of Menopause Treatment Revenue Global Market Share (%)(2013-2018)
    Table Pivot Pharmaceuticals Inc Basic Information List
    Table Pivot Pharmaceuticals Inc Vasomotor Symptoms of Menopause Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
    Figure Pivot Pharmaceuticals Inc Vasomotor Symptoms of Menopause Treatment Sales Growth Rate (2013-2018)
    Figure Pivot Pharmaceuticals Inc Vasomotor Symptoms of Menopause Treatment Sales Global Market Share (%)(2013-2018)
    Figure Pivot Pharmaceuticals Inc Vasomotor Symptoms of Menopause Treatment Revenue Global Market Share (%)(2013-2018)
    Table Radius Health, Inc. Basic Information List
    Table Radius Health, Inc. Vasomotor Symptoms of Menopause Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
    Figure Radius Health, Inc. Vasomotor Symptoms of Menopause Treatment Sales Growth Rate (2013-2018)
    Figure Radius Health, Inc. Vasomotor Symptoms of Menopause Treatment Sales Global Market Share (%)(2013-2018)
    Figure Radius Health, Inc. Vasomotor Symptoms of Menopause Treatment Revenue Global Market Share (%)(2013-2018)
    Table TherapeuticsMD, Inc. Basic Information List
    Table TherapeuticsMD, Inc. Vasomotor Symptoms of Menopause Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
    Figure TherapeuticsMD, Inc. Vasomotor Symptoms of Menopause Treatment Sales Growth Rate (2013-2018)
    Figure TherapeuticsMD, Inc. Vasomotor Symptoms of Menopause Treatment Sales Global Market Share (%)(2013-2018)
    Figure TherapeuticsMD, Inc. Vasomotor Symptoms of Menopause Treatment Revenue Global Market Share (%)(2013-2018)
    Table Sales Base and Market Concentration Rate of Raw Material
    Figure Price Trend of Key Raw Materials
    Table Key Suppliers of Raw Materials
    Figure Manufacturing Cost Structure of Vasomotor Symptoms of Menopause Treatment
    Figure Vasomotor Symptoms of Menopause Treatment Industrial Chain Analysis
    Table Major Buyers of Vasomotor Symptoms of Menopause Treatment
    Table Distributors/Traders List
    Figure Global Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
    Figure Global Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
    Figure United States Vasomotor Symptoms of Menopause TreatmentVasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
    Figure United States Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
    Table Global Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) Forecast by Regions (2018-2025)
    Figure Global Vasomotor Symptoms of Menopause Treatment Sales Market Share (%) Forecast by Regions (2018-2025)
    Figure North America Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
    Figure North America Vasomotor Symptoms of Menopause Treatment Revenue and Growth Rate (%) Forecast (2018-2025)
    Figure Europe Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
    Figure Europe Vasomotor Symptoms of Menopause Treatment Revenue and Growth Rate (%) Forecast (2018-2025)
    Figure Asia-Pacific Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
    Figure Asia-Pacific Vasomotor Symptoms of Menopause Treatment Revenue and Growth Rate (%) Forecast (2018-2025)
    Figure South America Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
    Figure South America Vasomotor Symptoms of Menopause Treatment Revenue and Growth Rate (%) Forecast (2018-2025)
    Figure Middle East and Africa Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
    Figure Middle East and Africa Vasomotor Symptoms of Menopause Treatment Revenue and Growth Rate (%) Forecast (2018-2025)
    Table Global Vasomotor Symptoms of Menopause Treatment Sales (Million USD) Forecast by Type (2018-2025)
    Figure Global Vasomotor Symptoms of Menopause Treatment Sales Market Share (%) Forecast by Type (2018-2025)
    Table Global Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) Forecast by Type (2018-2025)
    Figure Global Vasomotor Symptoms of Menopause Treatment Revenue Market Share (%) Forecast by Type (2018-2025)
    Table United States Vasomotor Symptoms of Menopause Treatment Sales (Million USD) Forecast by Type (2018-2025)
    Figure United States Vasomotor Symptoms of Menopause Treatment Sales Market Share (%) Forecast by Type (2018-2025)
    Table United States Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) Forecast by Type (2018-2025)
    Figure United States Vasomotor Symptoms of Menopause Treatment Revenue Market Share (%) Forecast by Type (2018-2025)
    Table Global Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) Forecast by Application (2018-2025)
    Figure Global Vasomotor Symptoms of Menopause Treatment Sales Forecast by Application (2018-2025)
    Table United States Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) Forecast by Application (2018-2025)
    Figure United States Vasomotor Symptoms of Menopause Treatment Sales Forecast by Application (2018-2025)



 Select a Format



 Buy Now

24/7 Customer Support

Have questions?

Direct
+1-386-310-3803
Toll Free
+1-855-465-4651
sales@e-marketresearch.com